154 related articles for article (PubMed ID: 37592765)
1. Inhibition of non-homologous end joining mitigates paclitaxel resistance resulting from mitotic slippage in non-small cell lung cancer.
Tsuji K; Kikuchi E; Takashima Y; Shoji T; Takahashi H; Ito S; Morinaga D; Kashima M; Maeda M; Kitai H; Kikuchi J; Sakakibara-Konishi J; Konno S
Cell Cycle; 2023 Sep; 22(17):1854-1864. PubMed ID: 37592765
[TBL] [Abstract][Full Text] [Related]
2. Targeting mitotic exit with hyperthermia or APC/C inhibition to increase paclitaxel efficacy.
Giovinazzi S; Bellapu D; Morozov VM; Ishov AM
Cell Cycle; 2013 Aug; 12(16):2598-607. PubMed ID: 23907120
[TBL] [Abstract][Full Text] [Related]
3. Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer.
Sun H; Zhou X; Bao Y; Xiong G; Cui Y; Zhou H
Open Biol; 2019 Jul; 9(7):180227. PubMed ID: 31337279
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Anticancer Activity of Combined Use of Caffeic Acid with Paclitaxel Enhances Apoptosis of Non-Small-Cell Lung Cancer H1299 Cells in Vivo and in Vitro.
Min J; Shen H; Xi W; Wang Q; Yin L; Zhang Y; Yu Y; Yang Q; Wang ZN
Cell Physiol Biochem; 2018; 48(4):1433-1442. PubMed ID: 30064123
[TBL] [Abstract][Full Text] [Related]
5. Potential monoamine oxidase A inhibitor suppressing paclitaxel-resistant non-small cell lung cancer metastasis and growth.
Yang X; Zhao D; Li Y; Li Y; Cui W; Li Y; Li H; Li X; Wang D
Thorac Cancer; 2020 Oct; 11(10):2858-2866. PubMed ID: 32875729
[TBL] [Abstract][Full Text] [Related]
6. Bromodomain and extraterminal domain inhibition synergizes with WEE1-inhibitor AZD1775 effect by impairing nonhomologous end joining and enhancing DNA damage in nonsmall cell lung cancer.
Takashima Y; Kikuchi E; Kikuchi J; Suzuki M; Kikuchi H; Maeda M; Shoji T; Furuta M; Kinoshita I; Dosaka-Akita H; Sakakibara-Konishi J; Konno S
Int J Cancer; 2020 Feb; 146(4):1114-1124. PubMed ID: 31199520
[TBL] [Abstract][Full Text] [Related]
7. Post-slippage multinucleation renders cytotoxic variation in anti-mitotic drugs that target the microtubules or mitotic spindle.
Zhu Y; Zhou Y; Shi J
Cell Cycle; 2014; 13(11):1756-64. PubMed ID: 24694730
[TBL] [Abstract][Full Text] [Related]
8. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
Giannakakou P; Robey R; Fojo T; Blagosklonny MV
Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
[TBL] [Abstract][Full Text] [Related]
9. Combination of Paclitaxel and PXR Antagonist SPA70 Reverses Paclitaxel-Resistant Non-Small Cell Lung Cancer.
Niu X; Wu T; Yin Q; Gu X; Li G; Zhou C; Ma M; Su L; Tang S; Tian Y; Yang M; Cui H
Cells; 2022 Oct; 11(19):. PubMed ID: 36231056
[TBL] [Abstract][Full Text] [Related]
10. Cell Division Cycle 6 Promotes Mitotic Slippage and Contributes to Drug Resistance in Paclitaxel-Treated Cancer Cells.
He Y; Yan D; Zheng D; Hu Z; Li H; Li J
PLoS One; 2016; 11(9):e0162633. PubMed ID: 27611665
[TBL] [Abstract][Full Text] [Related]
11. Targeted paclitaxel-octreotide conjugates inhibited the growth of paclitaxel-resistant human non-small cell lung cancer A549 cells in vitro.
Liu Y; Xia H; Wang Y; Han W; Qin J; Gao W; Qu X; Wang X
Thorac Cancer; 2021 Nov; 12(22):3053-3061. PubMed ID: 34617400
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis.
Demidenko ZN; Kalurupalle S; Hanko C; Lim CU; Broude E; Blagosklonny MV
Oncogene; 2008 Jul; 27(32):4402-10. PubMed ID: 18469851
[TBL] [Abstract][Full Text] [Related]
13. Blocking circ_0010235 suppresses acquired paclitaxel resistance of non-small cell lung cancer by sponging miR-512-5p to modulate FAM83F expression.
Li Y; Ma Z; Luo M; Liang R
Anticancer Drugs; 2022 Nov; 33(10):1024-1034. PubMed ID: 36206095
[TBL] [Abstract][Full Text] [Related]
14. Hsa_circ_0092887 targeting miR-490-5p/UBE2T promotes paclitaxel resistance in non-small cell lung cancer.
Wang L; Zhang Z; Tian H
J Clin Lab Anal; 2023 Jan; 37(1):e24781. PubMed ID: 36550019
[TBL] [Abstract][Full Text] [Related]
15. Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo.
Chen S; Zhang Z; Zhang J
Drug Des Devel Ther; 2019; 13():1145-1153. PubMed ID: 31114158
[No Abstract] [Full Text] [Related]
16. SOX2 regulates paclitaxel resistance of A549 non‑small cell lung cancer cells via promoting transcription of ClC‑3.
Huang Y; Wang X; Hu R; Pan G; Lin X
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36069232
[TBL] [Abstract][Full Text] [Related]
17. [Tumor growth inhibition of paclitaxel-octreotide conjugates on human non small cell lung cancer: experiment with mice].
Shen HC; Wang XW; Liu YG
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2498-503. PubMed ID: 19080633
[TBL] [Abstract][Full Text] [Related]
18. An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer.
Wang W; Wang J; Liu S; Ren Y; Wang J; Liu S; Cui W; Jia L; Tang X; Yang J; Wu C; Wang L
Mol Cancer; 2022 Apr; 21(1):106. PubMed ID: 35477569
[TBL] [Abstract][Full Text] [Related]
19. Analysis of mitosis and antimitotic drug responses in tumors by in vivo microscopy and single-cell pharmacodynamics.
Orth JD; Kohler RH; Foijer F; Sorger PK; Weissleder R; Mitchison TJ
Cancer Res; 2011 Jul; 71(13):4608-16. PubMed ID: 21712408
[TBL] [Abstract][Full Text] [Related]
20. Gene expression and mitotic exit induced by microtubule-stabilizing drugs.
Chen JG; Yang CP; Cammer M; Horwitz SB
Cancer Res; 2003 Nov; 63(22):7891-9. PubMed ID: 14633718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]